Delving into Foundation Medicine's Recent ApprovalsDelving into Foundation Medicine's Recent Approvals
Dr. Geoffrey Oxnard vice president, global medical lead for Foundation Medicine's liquid biopsy portfolio, stops by Let's Talk Medtech to discuss the company’s recent FDA approvals. Oxnard also gives some insight into the liquid biopsy space.
November 15, 2020
Foundation Medicine has been busy with a number of approvals in recent weeks. The company, which was acquired by Roche in 2018 for $2.4 billion, recently won several approvals to be used as companion diagnostics.
Dr. Geoffrey Oxnard vice president, global medical lead for Foundation Medicine's liquid biopsy portfolio, stops by Let's Talk Medtech to discuss the company’s recent FDA approvals. Oxnard also gives some insight into the liquid biopsy space and the importance of tissue biopsies.
About the Author
You May Also Like